Skip to main content
Erschienen in: Virchows Archiv 1/2015

01.07.2015 | Original Article

Sclerosing adenosis as a predictor of breast cancer bilaterality and multicentricity

verfasst von: Mikinao Oiwa, Tokiko Endo, Shu Ichihara, Suzuko Moritani, Masaki Hasegawa, Akari Iwakoshi, Yasuyuki Sato, Takako Morita, Takako Hayashi, Aya Kato

Erschienen in: Virchows Archiv | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Breast cancer is occasionally complicated by sclerosing adenosis (SA). Although both lesions usually originate in the terminal duct lobular unit, their pathogenetic relationship has not yet been elucidated. The present study analyzed 63 breast cancer patients with SA (involving a total of 75 breasts) to clarify if coexisting SA increased the frequency of multicentric breast cancer or not. Using the topographical classification proposed in our previous study, breast cancers with SA were classified into the following three types: type A (n = 22), cancer area was completely surrounded by the SA; type B (n = 26), cancer area partially overlapped the SA; and type C (n = 27), cancer area was located separate from the SA. Breast cancers with SA had a significant (P < 0.001) increase in frequency of harboring bilateral and multicentric cancers [17 of 63 (27 %) and 15 of 63 (24 %), respectively] when compared to breast cancer patients without SA, regardless of topographical type. Breast cancers with SA were less invasive (P < 0.001), of lower histological grade (P = 0.034), and had similar frequency of estrogen receptor-positive (P = 0.21) and HER2-positive (P = 0.74) tumors. In conclusion, contralateral and ipsilateral multicentric breast cancers occurred at a higher frequency in those with SA. Our data suggest that SA is, in addition to lobular neoplasia, a predictor of multicentric breast cancers.
Literatur
2.
Zurück zum Zitat Franquet T, de Miguel C, Cozcolluela R, Donoso L (1993) Spiculated lesions of the breast: mammographic-pathologic correlation. Radiographics 13:841–852PubMedCrossRef Franquet T, de Miguel C, Cozcolluela R, Donoso L (1993) Spiculated lesions of the breast: mammographic-pathologic correlation. Radiographics 13:841–852PubMedCrossRef
3.
Zurück zum Zitat Sekine K, Tsunoda-Shimizu H, Kikuchi M, Saida Y, Kawasaki T, Suzuki K (2007) DCIS showing architectural distortion on the screening mammogram—comparison of mammographic and pathological findings. Breast Cancer 14:281–284PubMedCrossRef Sekine K, Tsunoda-Shimizu H, Kikuchi M, Saida Y, Kawasaki T, Suzuki K (2007) DCIS showing architectural distortion on the screening mammogram—comparison of mammographic and pathological findings. Breast Cancer 14:281–284PubMedCrossRef
4.
Zurück zum Zitat Pojchamarnwiputh S, Muttarak M, Na-Chiangmai W, Chaiwun B (2007) Benign breast lesions mimicking carcinoma at mammography. Singap Med J 48:958–968 Pojchamarnwiputh S, Muttarak M, Na-Chiangmai W, Chaiwun B (2007) Benign breast lesions mimicking carcinoma at mammography. Singap Med J 48:958–968
5.
Zurück zum Zitat Rosen PP (2009) Adenosis, invasive lobular carcinoma. In: Pine JW, McGough J (eds) Breast pathology, 3rd edn. Lippincott Williams and Wilkins, Philadelphia, pp 161–175, 690–720 Rosen PP (2009) Adenosis, invasive lobular carcinoma. In: Pine JW, McGough J (eds) Breast pathology, 3rd edn. Lippincott Williams and Wilkins, Philadelphia, pp 161–175, 690–720
6.
Zurück zum Zitat Jensen RA, Page DL, Dupont WD, Rogers LW (1989) Invasive breast cancer risk in women with sclerosing adenosis. Cancer 64:1977–1983PubMedCrossRef Jensen RA, Page DL, Dupont WD, Rogers LW (1989) Invasive breast cancer risk in women with sclerosing adenosis. Cancer 64:1977–1983PubMedCrossRef
7.
Zurück zum Zitat Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton LJ 3rd, Visscher DW (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353:229–237PubMedCrossRef Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton LJ 3rd, Visscher DW (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353:229–237PubMedCrossRef
8.
Zurück zum Zitat Visscher DW, Nassar A, Degnim AC, Frost MH, Vierkant RA, Frank RD, Tarabishy Y, Radisky DC, Hartmann LC (2014) Sclerosing adenosis and risk of breast cancer. Breast Cancer Res Treat 144:205–212PubMedCentralPubMedCrossRef Visscher DW, Nassar A, Degnim AC, Frost MH, Vierkant RA, Frank RD, Tarabishy Y, Radisky DC, Hartmann LC (2014) Sclerosing adenosis and risk of breast cancer. Breast Cancer Res Treat 144:205–212PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Moritani S, Ichihara S, Hasegawa M, Endo T, Oiwa M, Shiraiwa M, Nishida C, Morita T, Sato Y, Hayashi T, Kato A, Aoyama H, Yoshikawa K (2011) Topographical, morphological and immunohistochemical characteristics of carcinoma in situ of the breast involving sclerosing adenosis. Two distinct topographical patterns and histological types of carcinoma in situ. Histopathology 58:835–846PubMedCrossRef Moritani S, Ichihara S, Hasegawa M, Endo T, Oiwa M, Shiraiwa M, Nishida C, Morita T, Sato Y, Hayashi T, Kato A, Aoyama H, Yoshikawa K (2011) Topographical, morphological and immunohistochemical characteristics of carcinoma in situ of the breast involving sclerosing adenosis. Two distinct topographical patterns and histological types of carcinoma in situ. Histopathology 58:835–846PubMedCrossRef
10.
Zurück zum Zitat Oiwa M, Endo T, Shiraiwa M, Nishida C, Morita T, Sato Y, Hayashi T, Kato A, Ichihara S, Moritani S, Hasegawa M, Shinohara N (2011) A clinical and histopathological study on breast carcinoma with sclerosing adenosis (in Japanese with English abstract). J Jpn Assoc Breast Cancer Screen 20:196–203CrossRef Oiwa M, Endo T, Shiraiwa M, Nishida C, Morita T, Sato Y, Hayashi T, Kato A, Ichihara S, Moritani S, Hasegawa M, Shinohara N (2011) A clinical and histopathological study on breast carcinoma with sclerosing adenosis (in Japanese with English abstract). J Jpn Assoc Breast Cancer Screen 20:196–203CrossRef
11.
Zurück zum Zitat Yoshida A, Hayashi N, Akiyama F, Yamauchi H, Uruno T, Kikuchi M, Yagata H, Tsugawa K, Suzuki K, Nakamura S, Tsunoda H (2012) Ductal carcinoma in Situ that involves sclerosing adenosis: high frequency of bilateral breast cancer occurrence. Clin Breast Cancer 12:398–403PubMedCrossRef Yoshida A, Hayashi N, Akiyama F, Yamauchi H, Uruno T, Kikuchi M, Yagata H, Tsugawa K, Suzuki K, Nakamura S, Tsunoda H (2012) Ductal carcinoma in Situ that involves sclerosing adenosis: high frequency of bilateral breast cancer occurrence. Clin Breast Cancer 12:398–403PubMedCrossRef
12.
Zurück zum Zitat Ogura K, Horii R, Oosako T, Iwase T, Akiyama F (2013) A clinico-pathological study on cancer in sclerosing adenosis. Breast Cancer. Published online 14 Feb. doi: 10.1007/s12282-013-0450-x Ogura K, Horii R, Oosako T, Iwase T, Akiyama F (2013) A clinico-pathological study on cancer in sclerosing adenosis. Breast Cancer. Published online 14 Feb. doi: 10.​1007/​s12282-013-0450-x
13.
Zurück zum Zitat Nichol AM, Yerushalmi R, Tyldesley S, Lesperance M, Bajdik CD, Speers C, Gelmon KA, Olivotto IA (2011) A case-match study comparing unilateral with synchronous bilateral breast cancer outcomes. J Clin Oncol 29:4763–4768PubMedCrossRef Nichol AM, Yerushalmi R, Tyldesley S, Lesperance M, Bajdik CD, Speers C, Gelmon KA, Olivotto IA (2011) A case-match study comparing unilateral with synchronous bilateral breast cancer outcomes. J Clin Oncol 29:4763–4768PubMedCrossRef
14.
Zurück zum Zitat Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403–410PubMedCrossRef Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403–410PubMedCrossRef
15.
Zurück zum Zitat Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love R, Mangu PB, McShane L, Miller K, Osborne CK, Paik S, Perlmutter J, Rhodes A, Sasano H, Schwartz JN, Sweep FC, Taube S, Torlakovic EE, Valenstein P, Viale G, Visscher D, Wheeler T, Williams RB, Wittliff JL, Wolff AC (2010) American society of clinical oncology/college of American pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28:2784–2795PubMedCentralPubMedCrossRef Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love R, Mangu PB, McShane L, Miller K, Osborne CK, Paik S, Perlmutter J, Rhodes A, Sasano H, Schwartz JN, Sweep FC, Taube S, Torlakovic EE, Valenstein P, Viale G, Visscher D, Wheeler T, Williams RB, Wittliff JL, Wolff AC (2010) American society of clinical oncology/college of American pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28:2784–2795PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF (2007) American society of clinical oncology/college of American pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25:118–145PubMedCrossRef Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF (2007) American society of clinical oncology/college of American pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25:118–145PubMedCrossRef
17.
Zurück zum Zitat Tavassoli FA (1999) General considerations, Benign lesions. In: Medina MP, Greenfield S (eds) Pathology of the breast, 2nd edn. Appleton and Lange, Stamford, pp 32–34, 130-133 Tavassoli FA (1999) General considerations, Benign lesions. In: Medina MP, Greenfield S (eds) Pathology of the breast, 2nd edn. Appleton and Lange, Stamford, pp 32–34, 130-133
18.
Zurück zum Zitat Günhan-Bilgen I, Memiş A, Ustün EE, Ozdemir N, Erhan Y (2002) Sclerosing adenosis: mammographic and ultrasonographic findings with clinical and histopathological correlation. Eur J Radiol 44(3):232–238PubMedCrossRef Günhan-Bilgen I, Memiş A, Ustün EE, Ozdemir N, Erhan Y (2002) Sclerosing adenosis: mammographic and ultrasonographic findings with clinical and histopathological correlation. Eur J Radiol 44(3):232–238PubMedCrossRef
19.
Zurück zum Zitat Taşkin F, Köseoğlu K, Unsal A, Erkuş M, Ozbaş S, Karaman C (2011) Sclerosing adenosis of the breast: radiologic appearance and efficiency of core needle biopsy. Diagn Interv Radiol 17:311–316PubMed Taşkin F, Köseoğlu K, Unsal A, Erkuş M, Ozbaş S, Karaman C (2011) Sclerosing adenosis of the breast: radiologic appearance and efficiency of core needle biopsy. Diagn Interv Radiol 17:311–316PubMed
20.
Zurück zum Zitat Ichihara S, Aoyama H (1994) Incidental carcinoma of the breast arising in sclerosing adenosis. Pathol Int 44:722–726PubMedCrossRef Ichihara S, Aoyama H (1994) Incidental carcinoma of the breast arising in sclerosing adenosis. Pathol Int 44:722–726PubMedCrossRef
21.
Zurück zum Zitat Sloane JP, Mayers MM (1993) Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: importance of lesion size and patient age. Histopathology 23:225–231PubMedCrossRef Sloane JP, Mayers MM (1993) Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: importance of lesion size and patient age. Histopathology 23:225–231PubMedCrossRef
22.
Zurück zum Zitat Shoker BS, Jarvis C, Clarke RB, Anderson E, Munro C, Davies MP, Sibson DR, Sloane JP (2000) Abnormal regulation of the oestrogen receptor in benign breast lesions. J Clin Pathol 53:778–783PubMedCentralPubMedCrossRef Shoker BS, Jarvis C, Clarke RB, Anderson E, Munro C, Davies MP, Sibson DR, Sloane JP (2000) Abnormal regulation of the oestrogen receptor in benign breast lesions. J Clin Pathol 53:778–783PubMedCentralPubMedCrossRef
23.
Zurück zum Zitat Selim AG, El-Ayat G, Wells CA (2002) Expression of c-erbB2, p53, Bcl-2, Bax, c-myc and Ki-67 in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast. Virchows Arch 441:449–455PubMedCrossRef Selim AG, El-Ayat G, Wells CA (2002) Expression of c-erbB2, p53, Bcl-2, Bax, c-myc and Ki-67 in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast. Virchows Arch 441:449–455PubMedCrossRef
24.
Zurück zum Zitat Celis JE, Moreira JM, Gromova I, Cabezón T, Gromov P, Shen T, Timmermans V, Rank F (2007) Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia. Mol Oncol 1:97–119PubMedCrossRef Celis JE, Moreira JM, Gromova I, Cabezón T, Gromov P, Shen T, Timmermans V, Rank F (2007) Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia. Mol Oncol 1:97–119PubMedCrossRef
25.
26.
Zurück zum Zitat Latta EK, Tjan S, Parkes RK, O’Malley FP (2002) The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast. Mod Pathol 15:1318–1325PubMedCrossRef Latta EK, Tjan S, Parkes RK, O’Malley FP (2002) The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast. Mod Pathol 15:1318–1325PubMedCrossRef
27.
Zurück zum Zitat van Bockstal M, Lambein K, Denys H, Braems G, Nuyts A, van den Broecke R, Cocquyt V, de Wever O, Libbrecht L (2014) Histopathological characterization of ductal carcinoma in situ (DCIS) of the breast according to HER2 amplification status and molecular subtype. Virchows Arch 465:275–289PubMedCrossRef van Bockstal M, Lambein K, Denys H, Braems G, Nuyts A, van den Broecke R, Cocquyt V, de Wever O, Libbrecht L (2014) Histopathological characterization of ductal carcinoma in situ (DCIS) of the breast according to HER2 amplification status and molecular subtype. Virchows Arch 465:275–289PubMedCrossRef
29.
Zurück zum Zitat Eusebi V, Collina G, Bussolati G (1989) Carcinoma in situ in sclerosing adenosis of the breast: an immnocytochemical study. Semin Diagn Pathol 6:146–152PubMed Eusebi V, Collina G, Bussolati G (1989) Carcinoma in situ in sclerosing adenosis of the breast: an immnocytochemical study. Semin Diagn Pathol 6:146–152PubMed
30.
Zurück zum Zitat Oberman HA, Markey BA (1991) Noninvasive carcinoma of the breast presenting in adenosis. Mod Pathol 4:31–35PubMed Oberman HA, Markey BA (1991) Noninvasive carcinoma of the breast presenting in adenosis. Mod Pathol 4:31–35PubMed
31.
Zurück zum Zitat Chen JJ, Wang Y, Xue JY, Chen Y, Chen YL, Xiao Q, Yang WT, Shao ZM, Wu J (2014) A clinicopathological study of early-stage synchronous bilateral breast cancer: a retrospective evaluation and prospective validation of potential risk factors. PLoS One. doi:10.1371/journal.pone.0095185 Chen JJ, Wang Y, Xue JY, Chen Y, Chen YL, Xiao Q, Yang WT, Shao ZM, Wu J (2014) A clinicopathological study of early-stage synchronous bilateral breast cancer: a retrospective evaluation and prospective validation of potential risk factors. PLoS One. doi:10.​1371/​journal.​pone.​0095185
32.
Zurück zum Zitat Faverly DR, Burgers L, Bult P, Holland R (1994) Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol 11:193–198PubMed Faverly DR, Burgers L, Bult P, Holland R (1994) Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol 11:193–198PubMed
Metadaten
Titel
Sclerosing adenosis as a predictor of breast cancer bilaterality and multicentricity
verfasst von
Mikinao Oiwa
Tokiko Endo
Shu Ichihara
Suzuko Moritani
Masaki Hasegawa
Akari Iwakoshi
Yasuyuki Sato
Takako Morita
Takako Hayashi
Aya Kato
Publikationsdatum
01.07.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 1/2015
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-015-1769-9

Weitere Artikel der Ausgabe 1/2015

Virchows Archiv 1/2015 Zur Ausgabe

Neu im Fachgebiet Pathologie

Open Access 15.04.2024 | Biomarker | Schwerpunkt: Next Generation Pathology

Molekularpathologische Untersuchungen im Wandel der Zeit

11.04.2024 | Pathologie | Schwerpunkt: Next Generation Pathology

Vergleichende Pathologie in der onkologischen Forschung

Open Access 08.04.2024 | GIST | CME

Gastrointestinale Stromatumoren

Wo stehen wir?

03.04.2024 | Zielgerichtete Therapie | Schwerpunkt: Next Generation Pathology

Personalisierte Medizin in der Onkologie